Trevena TRVN Stock
Trevena Price Chart
Trevena TRVN Financial and Trading Overview
| Trevena stock price | 0.38 USD |
| Previous Close | 1.01 USD |
| Open | 1.01 USD |
| Bid | 0 USD x 900 |
| Ask | 0 USD x 3200 |
| Day's Range | 1.01 - 1.04 USD |
| 52 Week Range | 0.58 - 12.23 USD |
| Volume | 227.98K USD |
| Avg. Volume | 2.88M USD |
| Market Cap | 11.41M USD |
| Beta (5Y Monthly) | 2.017253 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3.16 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 20 USD |
TRVN Valuation Measures
| Enterprise Value | 4.01M USD |
| Trailing P/E | N/A |
| Forward P/E | -1.7049179 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | -26.406853 |
| Price/Book (mrq) | 0.91954017 |
| Enterprise Value/Revenue | -9.274 |
| Enterprise Value/EBITDA | -0.081 |
Trading Information
Trevena Stock Price History
| Beta (5Y Monthly) | 2.017253 |
| 52-Week Change | -90.48% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 12.23 USD |
| 52 Week Low | 0.58 USD |
| 50-Day Moving Average | 1.01 USD |
| 200-Day Moving Average | 2.25 USD |
TRVN Share Statistics
| Avg. Volume (3 month) | 2.88M USD |
| Avg. Daily Volume (10-Days) | 403.82K USD |
| Shares Outstanding | 10.97M |
| Float | 10.87M |
| Short Ratio | 0.06 |
| % Held by Insiders | 3.33% |
| % Held by Institutions | 15.61% |
| Shares Short | 441.93K |
| Short % of Float | 4.07% |
| Short % of Shares Outstanding | 4.03% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:25 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 11585.18% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -60.90% |
| Return on Equity (ttm) | -151.47% |
Income Statement
| Revenue (ttm) | -432000 USD |
| Revenue Per Share (ttm) | -0.055 USD |
| Quarterly Revenue Growth (yoy) | -70.00000000000000000000000000000000% |
| Gross Profit (ttm) | -3436000 USD |
| EBITDA | -49689000 USD |
| Net Income Avi to Common (ttm) | -45100000 USD |
| Diluted EPS (ttm) | -6.04 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 27.44M USD |
| Total Cash Per Share (mrq) | 2.5 USD |
| Total Debt (mrq) | 19.6M USD |
| Total Debt/Equity (mrq) | 192.99 USD |
| Current Ratio (mrq) | 3.837 |
| Book Value Per Share (mrq) | 1.131 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -44094000 USD |
| Levered Free Cash Flow (ttm) | -27449750 USD |
Profile of Trevena
| Country | United States |
| State | PA |
| City | Chesterbrook |
| Address | 955 Chesterbrook Boulevard |
| ZIP | 19087 |
| Phone | 610 354 8840 |
| Website | https://www.trevena.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 35 |
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV250, a G protein biased delta-opioid receptor agonist for the treatment of acute migraine; TRV734, a small molecule G protein biased ligand of the MOR for the treatment of moderate-to-severe acute and chronic pain; and TRV045, a novel S1P modulator for managing chronic pain. Trevena, Inc. was incorporated in 2007 and is based in Chesterbrook, Pennsylvania.
Q&A For Trevena Stock
What is a current TRVN stock price?
Trevena TRVN stock price today per share is 0.38 USD.
How to purchase Trevena stock?
You can buy TRVN shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Trevena?
The stock symbol or ticker of Trevena is TRVN.
Which industry does the Trevena company belong to?
The Trevena industry is Biotechnology.
How many shares does Trevena have in circulation?
The max supply of Trevena shares is 18.32M.
What is Trevena Price to Earnings Ratio (PE Ratio)?
Trevena PE Ratio is now.
What was Trevena earnings per share over the trailing 12 months (TTM)?
Trevena EPS is -3.16 USD over the trailing 12 months.
Which sector does the Trevena company belong to?
The Trevena sector is Healthcare.
Trevena TRVN included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Composite Total Return I XCMP | 19659.36 USD — |
-1.62
|
— — | 19598.88 USD — | 19861.56 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
| NASDAQ Biotechnology Total Retu XNBI | 4501.69 USD — |
-2.14
|
— — | 4479.13 USD — | 4578.05 USD — | — - | — — |
- {{ link.label }} {{link}}